UCL-led trial shows adding niraparib to standard therapy reduces tumour growth risk in men with advanced prostate cancer by up to 37%, with greater effect in specific genetic subgroups.
Research has found that low-intensity transcranial ultrasound stimulation can modulate brain activity and behaviours, supporting the observations of psychiatric conditions.
In Israel, healthcare professionals and those over 60 are now being encouraged to take the fourth booster dose - which appears to significantly increase waning third dose antibodies.
According to data from two million people in Scotland and 42 million people in Brazil, AstraZeneca vaccine protection drops significantly three months after double-dosing.
Members of the Breast Cancer & Environment Research Program walk us through what we need to know about oestrogen signalling, including environmental chemicals & links with breast cancer.
